FDA Investigator Charles R Bonapace, PhD

Charles R Bonapace, PhD has conducted inspections on 12 sites in 4 countries as of 06 Aug 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
12
Last Inspection Date:
06 Aug 2019
Investigator Role:
FDA Investigator
Redica ID:
100005464
Countries of Inspections:
India, United States of America, Canada, China
FDA Investigators that have inspected at least one site in common with Charles R Bonapace, PhD:
Amber G Wardwell, Ana P Barido, Andrew M Barlow, Andrew R Wasko, Anita R Michael, Arindam Dasgupta, PhD, Barbara J Holladay, Barbara Janine Breithaupt, Bei Yu, Betsy C Galliher, Brandon L Mariner, Byungja E Marciante, Carl A Anderson, Carla C Tuite, CDR Rochelle B Young, RPh, MSA, Chaltu Nwakijra, Charles A Snipes, PhD, Charles R Cote, RIC, Chase Bourke, PhD, Christian D Lynch (CDL), Christine M Whitby, CSO, Connie P Rezendes, Corey K Reno, Courtney N Long, Ct Viswanathan, PhD, Cynthia A Harris, MD, RN, Cynthia Jim, CSO, Cynthia White, Daniel J Roberts, Daniel L Aisen, Daniel R Azar, Darin S Wiegers, David L Chon, David P Vanhouten, Debra Bower, Denise L Burosh, Dina A Tallman, Dipesh K Shah, Donald B Mckechnie, Douglas A Campbell, Dr. Abhijit Raha, PhD, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dylan D Yao, MD, PhD, Ekaterina Allen, Emest F Bizjak, Erin L Mcfiren, Erin M Mcdowell, Gajendiran Mahadevan, PhD, Gary J Hagan, Gene R Gunn, Grace P Santos, Gregory W Smith, Hector Jcolon Torres, Heika R Bounds, Heika R Tait, Hugh M Mcclure, II, Hyojong Kwon, PhD, Jacqueline A O'shaughnessy, PhD, Jacqueline Mdiaz Albertini, James P Mcevoy, James R Birkenstamm, Jane M Kreis, Jasjeet K Sekhon, Jazmine N Brown, Jean M Mulinde, MD, Joanne M Schlossin, John A Kadavil, PhD, John Dan, Joseph L Despins, PhD, Julian C Hanson, Julie D Bringger, Jyoti B Patel, PhD, Kara A Scheibner, PhD, Kathryn A Krentz, Kendra L Brooks, Kenneth Nieves, Kent A Conforti, Kurt A Brorson, PhD, Lakisha M Williams, Lee Hong Pai Scherf, Linda S Leja, Lori J Silverstein, Lori S Lawless, Luis A Dasta, Lynette P Salisbury, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Martin J Guardia, Martin K Yau, PhD, Mary Jeanet Mcgarry, Matthew C Watson, Michael F Skelly, PhD, Michael L Casner, Mohsen Rajabi Abhari, FDA, Nebil A Oumer, Norman K Starks, Philip J Snoy, Rachel C Harrington, Richard Heath Coats, Robert L Hummel, Robin R Waller, Ronald R Ruff, Rory K Geyer, Rose Ashley, Sandra A Hughes, Scott B Laufenberg, Stephanie L Shapley, Steven P Donald, Sunitha K Rajaram, PhD, Susan F Laska, MS, Susan M Jackson, Susanne M Richardson, MS RAC, Toyin B Oladimeji, Vickie J Kanion, Victor J Gangi, Vlada Matusovsky, Xiaohan Cai, PhD, Xingfang Li, MD, Yangmin Ning, Zhongren Wu

Charles R Bonapace, PhD's Documents

Publish Date Document Type Title
March, 2018 EIR Citoxlab North America Inc - EIR, 2018-03-02
August, 2019 FDA 483 BioReliance Corporation - Form 483, 2019-08-08
September, 2011 FDA 483 Altasciences Preclinical Seattle, LLC - Form 483, 2011-09-27
February, 2014 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2014-02-20
October, 2015 FDA 483 Semler Research Center Private Limited - Form 483, 2015-10-09
February, 2014 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2014-02-20
August, 2019 FDA 483 Response BioReliance Corporation - Form 483R, 2019-08-08
February, 2014 EIR PPD Development, L.P. - EIR, 2014-02-13
February, 2012 FDA 483 Discovery Laboratories, Inc. - Form 483, 2012-02-24
September, 2013 FDA 483 Labcorp Bedford LLC. - Form 483, 2013-09-20
June, 2014 FDA 483 Wuxi Apptec Suzhou Co.,Ltd - Form 483, 2014-06-13
November, 2013 FDA 483 Altasciences Preclinical Seattle, LLC - Form 483, 2013-11-22
August, 2013 FDA 483 Janssen Research & Development, LLC - Form 483, 2013-08-09
August, 2019 EIR BioReliance Corporation - EIR, 2019-08-08
August, 2013 EIR Janssen Research & Development, LLC - EIR, 2013-08-09

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more